Artificial Intelligence

Capgemini's 2025 results show a strong pivot to AI, with bookings soaring and a €700M plan to reshape its workforce for a new era of tech.

With a fresh $25M, Uptiq is tackling AI's biggest hurdle in finance: moving from demos to deployment with its compliance-first Qore platform.

A new high-resolution spatial biology service in Hong Kong is set to accelerate research in cancer and neuroscience across the Asia-Pacific region.

Canada's largest P&C insurer swaps old debt for new capital, a strategic move to cut costs, enhance flexibility, and fuel its global expansion strategy.

After its lead anxiety drug failed a key trial, Vistagen turns to AI and a new menopause treatment to secure its future. Can the company recover?

Tokyo's premier contemporary art event explores the theme of time with 21 artists, AI installations, and a subway exit 250 meters in the sky.

Fermi America's plan to revive nuclear power for AI's energy needs with a massive Texas campus faces past industry failures and new legal scrutiny.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

Cohen & Co.-backed SPAC joins the hunt for a merger target, highlighting a renewed investor appetite for blank check companies in a maturing market.

With strong financials and a focus on tech, Allegion's CEO will outline the security giant's long-term strategy for a digitally connected world.

With top executives set for major conferences, investors eye Mastercard's playbook for commercial payments and Americas growth amid fierce competition.

With massive data center orders but cautious guidance, the industrial giant's upcoming conference talks are a key test of investor confidence.

Lay's emotional 'Last Harvest' was America's top Super Bowl ad, but a new report reveals a huge generational divide, with Gen Z crowning a different winner.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

Twilio reports a landmark year of GAAP profitability and robust growth, signaling a strategic pivot to AI as it guides for a billion in 2026 cash flow.

Aethlon Medical advances its Hemopurifier for oncology and Long COVID, but a shrinking cash reserve and rising quarterly loss test its lean science strategy.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

Semiconductor giant Victor Peng joins the Rambus board, signaling a strategic move to deepen its dominance in the competitive AI and data center markets.

The streaming pioneer smashed Q4 estimates and returned to full-year profitability, signaling a strong 2026 with ambitious growth targets for its ad platform.